Case File №
#VI-2026-0656
Xian Yihang Technology
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
37 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | C Okay | 6 | 7.1 | 4.0 | 8.0 | 10 Jul 2025 |
| Retatrutide | D Poor | 16 | 5.9 | 3.5 | 8.0 | 27 Jun 2025 |
| Tirzepatide | E Bad | 20 | 6.9 | 2.6 | 10.0 | 20 Jun 2025 |
| Tesamorelin | E Bad | 6 | 5.7 | 1.4 | 8.0 | 13 Jun 2025 |
| 5-amino-1MQ | X N/A | 2 | 7.1 | 5.1 | 9.2 | 20 May 2026 |
| ACE-031 | X N/A | 2 | 7.8 | 6.8 | 8.8 | 21 May 2026 |
| AICAR | X N/A | 3 | 5.7 | 3.6 | 8.2 | 24 May 2026 |
| Alprostadil | X N/A | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 |
| BAC Water | X N/A | 4 | 7.3 | 5.9 | 9.3 | 25 May 2026 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 2 | 7.8 | 7.6 | 7.9 | 24 May 2026 |
| Cerebrolysin | X N/A | 2 | 7.9 | 5.9 | 9.9 | 19 Jan 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 4 | 5.8 | 4.6 | 7.3 | 26 Jan 2026 |
| Dianabol Oil | X N/A | 4 | 6.3 | 5.2 | 7.8 | 24 May 2026 |
| DSIP | X N/A | 2 | 6.5 | 6.0 | 7.0 | 25 May 2026 |
| EPO | X N/A | 4 | 6.0 | 4.9 | 6.8 | 21 May 2026 |
| Estradiol Cypionate | X N/A | 3 | 7.3 | 6.9 | 7.9 | 20 May 2026 |
| GHRP-2 Acetate | X N/A | 1 | 5.2 | 5.2 | 5.2 | 17 Dec 2024 |
| Humanin | X N/A | 4 | 5.9 | 4.1 | 7.2 | 19 Jan 2026 |
| Hyaluronic acid | X N/A | 1 | 7.3 | 7.3 | 7.3 | 2 Apr 2025 |
| IGF-1 LR3 | X N/A | 2 | 5.5 | 4.4 | 6.5 | 20 May 2026 |
| KPV Oral | X N/A | 1 | 9.3 | 9.3 | 9.3 | 6 May 2025 |
| Livagen | X N/A | 3 | 5.5 | 3.4 | 7.9 | 21 May 2026 |
| MAPA (methyl alpha-phenylacetoacetate) CAS 101-97-3 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 11 Jun 2025 |
| MGF | X N/A | 4 | 6.5 | 6.0 | 7.3 | 24 May 2026 |
| MOTS-C | X N/A | 1 | 5.0 | 5.0 | 5.0 | 25 Apr 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 2 | 5.9 | 5.6 | 6.3 | 21 May 2026 |
| Pancragen | X N/A | 2 | 4.4 | 3.8 | 5.1 | 24 May 2026 |
| PE 22-28 | X N/A | 3 | 7.0 | 6.4 | 7.5 | 17 May 2026 |
| Pinealon | X N/A | 3 | 4.8 | 3.1 | 6.9 | 24 May 2026 |
| Prednisone | X N/A | 3 | 5.9 | 4.8 | 7.1 | 21 May 2026 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 2 | 7.1 | 5.3 | 8.8 | 23 May 2026 |
| Prostamax | X N/A | 3 | 5.8 | 3.5 | 7.5 | 17 May 2026 |
| Retatrutide 30mg Pen Kit | X N/A | 4 | 6.9 | 4.7 | 10.0 | 23 May 2026 |
| SR9009 | X N/A | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 |
| Supertest 450 | X N/A | 3 | 7.0 | 6.2 | 7.6 | 20 May 2026 |
| Sustanon 250 | X N/A | 3 | 5.1 | 3.6 | 5.9 | 21 May 2026 |
| Test Cypionate | X N/A | 1 | 7.8 | 7.8 | 7.8 | 17 Dec 2024 |
Exhibit II
Evidence Log
88 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | BAC Water | 8.7 A | 5mg | 6.1mg | +21.1% | 96.76% | niy3y6 | Lab E | Public |
| 24 May 2026 | Blend 300 (TRA/Mast P/Test P) | 9.4 A | 250mg/ml | 228.5mg/ml | -8.6% | 97.93% | xgsmvb | Lab G | Public |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 6.0 A | 50mg | 60.2mg | +20.3% | 95.24% | wuuhpk | Lab G | Public |
| 24 May 2026 | Retatrutide | 7.8 A | 5mg | 5.4mg | +8.0% | 99.40% | n/a | No Label / Silver Crimp / Yellow Cap | Lab G |
| 24 May 2026 | AICAR | 7.1 A | 5mg | 6.1mg | +21.7% | 96.68% | hz5h12 | Lab C | Public |
| 24 May 2026 | Alprostadil | 7.7 A | 30mg | 36.5mg | +21.6% | 99.05% | ljjvvo | Lab A | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.2 B | 10mg | 10.6mg | +5.8% | 95.85% | 5xclmg | Lab C | Community |
| 24 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.2 C | 15mg | 17.6mg | +17.2% | 96.09% | 0vzwl9 | Lab D | Community |
| 24 May 2026 | DSIP | 4.2 C | 20mg | 21.7mg | +8.7% | 99.32% | ca54ll | Lab E | Public |
| 24 May 2026 | EPO | 5.4 B | 10mg | 12.2mg | +21.5% | 96.26% | alp44q | Lab A | Community |
| 24 May 2026 | IGF-1 LR3 | 5.1 B | 10mg | 12.2mg | +21.7% | 99.37% | d4dmxi | Lab C | Public |
| 24 May 2026 | IGF-1 LR3 | 4.1 C | 30mg | 30.6mg | +2.1% | 95.78% | fxd5ik | Lab F | Public |
| 24 May 2026 | Pinealon | 4.1 C | 10mg | 12.0mg | +20.3% | 96.66% | hvn46p | Lab F | Public |
| 24 May 2026 | Retatrutide | 6.2 B | 20mg | 21.2mg | +6.0% | 99.29% | n/a | No Label / Copper Crimp / Clear Cap | Lab E |
| 24 May 2026 | BAC Water | 6.3 A | 30mg | 27.2mg | -9.4% | 98.38% | ftqzao | Lab B | Community |
| 24 May 2026 | Sustanon 250 | 5.6 B | 250mg/ml | 310.2mg/ml | +24.1% | 97.47% | obpz9k | Lab C | Public |
| 24 May 2026 | Retatrutide | 5.3 C | 30mg | 24.7mg | -17.7% | 99.90% | below LOQ | Silver Label / Silver Crimp / Violet Cap | Lab E |
| 24 May 2026 | BAC Water | 5.5 B | 15mg | 16.0mg | +6.5% | 95.31% | cipun7 | Lab F | Community |
| 24 May 2026 | PE 22-28 | 7.6 A | 20mg | 17.3mg | -13.3% | 96.62% | v5lpam | Lab B | Public |
| 24 May 2026 | Test Cypionate | 9.0 A | 300mg/ml | 315.5mg/ml | +5.2% | 98.74% | yf3nmr | Lab G | Public |
| 24 May 2026 | BAC Water | 7.9 A | 50mg | 59.4mg | +18.8% | 96.52% | h6m3h3 | Lab F | Community |
| 24 May 2026 | MGF | 7.5 A | 2mg | 2.3mg | +13.6% | 97.60% | lnr5g7 | Lab F | Public |
| 24 May 2026 | Pinealon | 5.2 B | 50mg | 48.4mg | -3.2% | 98.35% | 4eompf | Lab D | Community |
| 23 May 2026 | Retatrutide | 5.9 C | 10mg | 11.3mg | +13.0% | 99.90% | n/a | No Label / Silver Crimp / Green Cap | Lab E |
| 23 May 2026 | Dianabol Oil | 6.7 A | 250mg/ml | 226.5mg/ml | -9.4% | 99.09% | nkas18 | Lab A | Public |
| 23 May 2026 | MOTS-C | 5.1 B | 2mg | 2.3mg | +14.8% | 99.76% | fm06cj | Lab B | Public |
| 23 May 2026 | Pancragen | 4.0 C | 2mg | 2.3mg | +15.1% | 95.59% | i3w3dn | Lab F | Public |
| 23 May 2026 | MGF | 6.0 A | 50mg | 43.0mg | -14.0% | 97.99% | 3304ti | Lab F | Public |
| 23 May 2026 | Prednisone | 7.6 A | 100mg | 122.3mg | +22.3% | 98.13% | 3vu8hc | Lab C | Community |
| 21 May 2026 | Tirzepatide | 3.8 E | 5mg | 15.9mg | +218.0% | 99.80% | n/a | No Label / Silver Crimp / Clear Pink Cap | Lab G |
| 21 May 2026 | 5-amino-1MQ | 8.3 A | 10mg | 11.7mg | +16.9% | 99.77% | spqugv | Lab B | Public |
| 21 May 2026 | Tirzepatide | 4.5 D | 60mg | 66mg | +10.0% | 98.96% | n/a | No Label / Copper Crimp / Clear Cap | Lab E |
| 21 May 2026 | Tirzepatide | 7.5 A | 30mg | 31.9mg | +6.3% | 99.89% | n/a | No Label / Copper Crimp / Clear Cap | Lab E |
| 21 May 2026 | EPO | 5.1 B | 50mg | 51.8mg | +3.5% | 95.70% | kex0il | Lab D | Public |
| 21 May 2026 | EPO | 6.0 A | 2mg | 1.8mg | -11.4% | 99.56% | pfgmgu | Lab A | Public |
| 21 May 2026 | Pancragen | 4.2 C | 50mg | 53.0mg | +6.0% | 97.14% | 0ejj3q | Lab E | Community |
| 20 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.1 C | 5mg | 5.5mg | +9.6% | 96.97% | 3vux4r | Lab E | Public |
| 20 May 2026 | EPO | 6.4 A | 50mg | 58.8mg | +17.6% | 98.03% | htq63d | Lab D | Community |
| 20 May 2026 | Estradiol Cypionate | 5.5 B | 200mg/ml | 195.1mg/ml | -2.5% | 95.16% | aj9so3 | Lab B | Public |
| 20 May 2026 | Humanin | 4.0 C | 5mg | 4.9mg | -1.2% | 97.98% | xfwg35 | Lab B | Public |
| 19 May 2026 | Livagen | 4.6 C | 5mg | 5.6mg | +12.0% | 95.15% | u1qyv6 | Lab C | Public |
| 17 May 2026 | Livagen | 4.0 C | 15mg | 15.5mg | +3.1% | 97.77% | rzc19t | Lab B | Community |
| 17 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.0 B | 10mg | 9.4mg | -6.3% | 96.99% | 0kq5yb | Lab E | Community |
| 17 May 2026 | Prostamax | 4.0 C | 15mg | 14.5mg | -3.6% | 97.84% | m0aev3 | Lab D | Public |
| 29 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.9 B | 5mg | 5.5mg | +10.3% | 95.32% | 75tlu9 | Lab D | Public |
| 26 Jan 2026 | ACE-031 | 6.2 A | 10mg | 10.0mg | +0.1% | 99.07% | am92co | Lab A | Community |
| 26 Jan 2026 | Dianabol Oil | 6.6 A | 250mg/ml | 265.1mg/ml | +6.0% | 95.96% | g1cfbp | Lab A | Public |
| 26 Jan 2026 | Hyaluronic acid | 8.2 A | 15mg | 16.4mg | +9.4% | 96.27% | ee7g26 | Lab A | Community |
| 26 Jan 2026 | PE 22-28 | 5.6 B | 20mg | 19.9mg | -0.7% | 99.26% | w8xlw6 | Lab F | Public |
| 26 Jan 2026 | Pinealon | 4.3 C | 50mg | 60.1mg | +20.2% | 96.60% | d73t6h | Lab B | Public |
| 26 Jan 2026 | Sustanon 250 | 7.6 A | 300mg/ml | 337.8mg/ml | +12.6% | 96.32% | jmfpgq | Lab G | Public |
| 26 Jan 2026 | Sustanon 250 | 4.0 C | 300mg/ml | 272.8mg/ml | -9.1% | 95.01% | gtrjc7 | Lab D | Community |
| 19 Jan 2026 | GHRP-2 Acetate | 5.7 B | 2mg | 2.0mg | +1.1% | 96.54% | 0f1728 | Lab D | Public |
| 9 Jan 2026 | Prednisone | 6.4 A | 10mg | 11.6mg | +15.7% | 96.76% | rsnjdg | Lab F | Community |
| 9 Jan 2026 | SR9009 | 7.7 A | 20mg | 20.3mg | +1.6% | 98.15% | p83dds | Lab E | Public |
| 6 Jan 2026 | 5-amino-1MQ | 8.7 A | 10mg | 12.2mg | +22.1% | 96.10% | dw2cfo | Lab F | Public |
| 6 Jan 2026 | Prednisone | 5.3 B | 20mg | 18.6mg | -7.2% | 99.01% | sclh6h | Lab F | Community |
| 6 Jan 2026 | Primobolan Oral (Methenolone Acetate) | 6.3 A | 50mg | 45.1mg | -9.8% | 97.93% | 5daux1 | Lab E | Community |
| 29 Dec 2025 | AICAR | 4.0 C | 20mg | 19.8mg | -0.9% | 99.51% | cs0im3 | Lab B | Public |
| 29 Dec 2025 | DSIP | 7.8 A | 5mg | 4.5mg | -10.6% | 98.28% | y2wz51 | Lab G | Community |
| 29 Dec 2025 | Retatrutide 30mg Pen Kit | 8.2 A | 20mg | 22.8mg | +14.2% | 96.12% | yh6slq | Lab A | Community |
| 29 Dec 2025 | Retatrutide 30mg Pen Kit | 6.5 A | 50mg | 59.6mg | +19.3% | 97.77% | 4v0iqd | Lab C | Public |
| 12 Dec 2025 | Dianabol Oil | 5.9 B | 250mg/ml | 252.1mg/ml | +0.8% | 96.67% | pqqdoj | Lab G | Public |
| 12 Dec 2025 | Estradiol Cypionate | 9.6 A | 100mg/ml | 87.7mg/ml | -12.3% | 99.20% | 5pziie | Lab C | Community |
| 5 Dec 2025 | KPV Oral | 8.7 A | 25mg | 29.9mg | +19.6% | 96.93% | s0n77p | Lab C | Public |
| 5 Dec 2025 | MAPA (methyl alpha-phenylacetoacetate) CAS 101-97-3 | 6.8 A | 10g | 8.8g | -12.2% | 95.55% | 0bikel | Lab F | Public |
| 23 Nov 2025 | Blend 300 (TRA/Mast P/Test P) | 8.7 A | 100mg/ml | 114.2mg/ml | +14.2% | 97.55% | o3yk92 | Lab B | Community |
| 23 Nov 2025 | Humanin | 5.3 B | 20mg | 22.4mg | +12.1% | 99.84% | 1ecicu | Lab B | Community |
| 23 Nov 2025 | MGF | 8.9 A | 10mg | 10.3mg | +3.1% | 99.63% | na1bm2 | Lab F | Community |
| 23 Nov 2025 | Retatrutide 30mg Pen Kit | 6.9 A | 5mg | 5.3mg | +5.6% | 98.92% | nm2qzn | Lab G | Public |
| 17 Nov 2025 | MGF | 7.4 A | 2mg | 1.9mg | -4.6% | 98.67% | 4qr9fn | Lab F | Public |
| 17 Nov 2025 | PE 22-28 | 7.3 A | 50mg | 53.5mg | +6.9% | 98.46% | wl4sz7 | Lab A | Community |
| 14 Nov 2025 | Cerebrolysin | 6.4 A | 20mg | 24.3mg | +21.6% | 95.25% | 0j9rxl | Lab A | Public |
| 14 Nov 2025 | Humanin | 5.9 B | 10mg | 11.4mg | +13.6% | 98.83% | 176g0d | Lab B | Public |
| 5 Nov 2025 | AICAR | 7.4 A | 10mg | 10.6mg | +5.6% | 99.69% | u3lr7z | Lab G | Public |
| 5 Nov 2025 | Livagen | 7.8 A | 20mg | 22.5mg | +12.6% | 98.83% | 82i10i | Lab B | Community |
| 5 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.0 C | 15mg | 18.6mg | +23.8% | 95.12% | 5byiax | Lab D | Public |
| 5 Nov 2025 | Retatrutide 30mg Pen Kit | 8.0 A | 20mg | 18.5mg | -7.3% | 98.11% | p1t16t | Lab D | Public |
| 5 Nov 2025 | Supertest 450 | 6.2 A | 200mg/ml | 226.8mg/ml | +13.4% | 98.70% | xyi92l | Lab C | Community |
| 4 Nov 2025 | ACE-031 | 6.2 A | 15mg | 17.9mg | +19.5% | 98.88% | 4dx7bk | Lab G | Community |
| 4 Nov 2025 | Dianabol Oil | 6.4 A | 200mg/ml | 193.9mg/ml | -3.0% | 97.46% | 3y5gbi | Lab B | Public |
| 17 Oct 2025 | Estradiol Cypionate | 4.5 C | 300mg/ml | 261.3mg/ml | -12.9% | 96.42% | khz4jd | Lab A | Public |
| 17 Oct 2025 | Humanin | 5.5 B | 30mg | 29.3mg | -2.5% | 99.89% | 470shi | Lab G | Community |
| 9 Oct 2025 | Supertest 450 | 5.0 B | 300mg/ml | 303.4mg/ml | +1.1% | 97.01% | s1vzgn | Lab C | Public |
| 3 Oct 2025 | Cerebrolysin | 10.0 A | 15mg | 14.8mg | -1.5% | 99.18% | azy99y | Lab A | Community |
| 3 Oct 2025 | Prostamax | 4.8 C | 50mg | 51.3mg | +2.6% | 96.52% | 5chq8i | Lab E | Community |
| 3 Oct 2025 | Prostamax | 7.0 A | 5mg | 5.9mg | +18.8% | 95.27% | fy78gn | Lab E | Community |
| 3 Oct 2025 | Supertest 450 | 5.8 B | 250mg/ml | 284.6mg/ml | +13.9% | 96.54% | z67l7x | Lab D | Public |
— END OF EVIDENCE LOG —